Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs
- PMID: 26623693
- PMCID: PMC4731705
- DOI: 10.1164/rccm.201508-1533LE
Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs
Comment in
- 
  
  Reply: Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399-400. doi: 10.1164/rccm.201508-1625LE. Am J Respir Crit Care Med. 2015. PMID: 26623694 Free PMC article. No abstract available.
Comment on
- 
  
  Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP. Am J Respir Crit Care Med. 2015. PMID: 26177009 Free PMC article.
References
- 
    - Bor J, Moscoe E, Bärnighausen T. Three approaches to causal inference in regression discontinuity designs. Epidemiology. 2015;26:e28–e30, discussion e30. - PubMed
 
- 
    - Moscoe E, Bor J, Bärnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol. 2015;68:122–133. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        